Editor's Summaries of the Articles Published in This Issue of Molecular Medicine Communications

Clicks: 106
ID: 275537
2022
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
In this issue, Riaz et al., carried out a pharmacological investigation of Carvacrol against D-galactose-induced cognitive impairment in mice, Fawad and Tahir reviewed the existing and emerging therapies in amyotrophic lateral sclerosis, Jahan and colleagues did a comparative analysis of the hepatoprotective potential of Co-enzyme Q10 as a preventive and therapeutic agent in statin-induced hepatotoxicity, Sheikh et al., reviewed studies with angiotensin-converting enzyme (ACE) inhibitors; their efficacy, adverse effects, and the genetic influence on ACE inhibitors induced cough.
Reference Key
staff2022moleculareditor's Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Editorial Staff;
Journal Molecular Medicine Communications
Year 2022
DOI
83
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.